Overview

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

Status:
Withdrawn

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

This pilot clinical trial studies photodynamic therapy using temoporfin before surgery in treating patients with recurrent oral cavity or oropharyngeal cancer. Photodynamic therapy uses a drug, such as temoporfin, that is absorbed by tumor cells. The drug becomes active when it is exposed to light. When the drug is active, tumor cells are killed. Giving photodynamic therapy using temoporfin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

Phase:

N/A

Details

Lead Sponsor:

Roswell Park Cancer Institute

Collaborators:

Biolitec Pharma Ltd.
National Institutes of Health (NIH)

Treatments:

Temoporfin